Is 18FDG uptake useful to decide on chemotherapy in ER+/HER2- breast cancer?
Crossref DOI link: https://doi.org/10.1007/s00259-016-3430-5
Published Online: 2016-06-01
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Groheux, David
HindiƩ, Elif
License valid from 2016-06-01